Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillation

被引：30

作者：

Blass, Benjamin E. ^{[1
]}

Coburn, Keith ^{[1
]}

Lee, Wenlin ^{[1
]}

Fairweather, Nell ^{[1
]}

Fluxe, Andrew ^{[1
]}

Wu, Shengde ^{[1
]}

Janusz, John M. ^{[1
]}

Murawsky, Michael ^{[1
]}

Fadayel, Gina M. ^{[1
]}

Fang, Bin ^{[1
]}

Hare, Michelle ^{[1
]}

Ridgeway, Jim ^{[1
]}

White, Ron ^{[1
]}

Jackson, Chris ^{[1
]}

Djandjighian, Laurent ^{[1
]}

Hedges, Richard ^{[1
]}

Wireko, Fred C. ^{[1
]}

Ritter, Amanda L. ^{[1
]}

机构：

[1] Procter & Gamble Co, Hlth Care Res Ctr, Mason, OH 43040 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 17期

关键词：

atrial fibrillation; Kv1.5 ion channel; 1,2,3-triazole;

D O I：

10.1016/j.bmcl.2006.06.001

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of novel (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones were prepared and examined for utility as Kv1.5 channel blockers for the treatment of atrial fibrillation. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：4629 / 4632

页数：4

共 16 条

[1]

ADAMS AD, Patent No. 5350746

[2] 1,2,3-TRIAZOLE-[2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-BETA-D-RIBOFURANOSYL]-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOL 2'',2''-DIOXIDE) (TSAO) ANALOGS - SYNTHESIS AND ANTI-HIV-1 ACTIVITY [J].

ALVAREZ, R ;

VELAZQUEZ, S ;

SANFELIX, A ;

AQUARO, S ;

DECLERCQ, E ;

PERNO, CF ;

KARLSSON, A ;

BALZARINI, J ;

CAMARASA, MJ .

JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (24) :4185-4194

[3]

CAPPELLACCI L, 1994, 13 INT S MED CHEM, pP13

[4] SELECTIVE CLASS-III ANTIARRHYTHMIC AGENTS .1. BIS(ARYLALKYL)AMINES [J].

CROSS, PE ;

ARROWSMITH, JE ;

THOMAS, GN ;

GWILT, M ;

BURGES, RA ;

HIGGINS, AJ .

JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (04) :1151-1155

[5] SYNTHESIS AND BETA-LACTAMASE INHIBITORY ACTIVITY OF 6-[(1-HETEROARYLTHIOETHYL-1,2,3-TRIAZOL-4-YL)-METHYLENE]PENAM SULFONES [J].

IM, C ;

MAITI, SN ;

MICETICH, RG ;

DANESHTALAB, M ;

ATCHISON, K ;

PHILLIPS, OA ;

KUNUGITA, C .

JOURNAL OF ANTIBIOTICS, 1994, 47 (09) :1030-1040

[6] Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates [J].

Kannel, WB ;

Wolf, PA ;

Benjamin, EJ ;

Levy, D .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (8A) :2N-8N

[7]

KOHN E, Patent No. 9507695

[8] Dofetilide, a new class III antiarrhythmic agent [J].

Lenz, TL ;

Hilleman, DE .

PHARMACOTHERAPY, 2000, 20 (07) :776-786

[9]

LI GR, 1996, CIRC RES, V78, P907

[10] Rufinamide:: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy [J].

Pålhagen, S ;

Canger, R ;

Henriksen, O ;

van Parys, JA ;

Rivière, ME ;

Karolchyk, MA .

EPILEPSY RESEARCH, 2001, 43 (02) :115-124

← 1 2 →